Table 2. Percent Survival of Secondary... | American Society of Hematology

Table 2.

Percent Survival of Secondary Recipients of FR25Lin⁻ or R/O PKH26⁺ Cells

No. and Type of Cells Injected^*	% 30-Day Survival	Median Survival (days)^†
10 FR25Lin⁻ BM	20.0	19.0 (3/15)
100 FR25Lin⁻ BM	78.5	>60 (11/14)
1,000 FR25Lin⁻ BM	100.0	>60 (4/4)
100 FR25Lin⁻ Spleen	0.0	17.0 (0/20)
1,000 FR25Lin⁻ Spleen	0.0	16.0 (0/20)
10,000 FR25Lin⁻ Spleen	12.5	18.0 (1/8)

No. and Type of Cells Injected^*	% 30-Day Survival	Median Survival (days)^†
10 FR25Lin⁻ BM	20.0	19.0 (3/15)
100 FR25Lin⁻ BM	78.5	>60 (11/14)
1,000 FR25Lin⁻ BM	100.0	>60 (4/4)
100 FR25Lin⁻ Spleen	0.0	17.0 (0/20)
1,000 FR25Lin⁻ Spleen	0.0	16.0 (0/20)
10,000 FR25Lin⁻ Spleen	12.5	18.0 (1/8)

Animals received number of FR25Lin⁻ cells indicated + 20,000 female R/O cells.

Numbers in parentheses represent number alive/number injected. Animals receiving 20,000 female R/O cells alone died at 17 to 19 days.